Why we need even better formulated premix insulin ?

What is it about?

Premix insulin is commonly used in clinical practice to treat type 2 diabetes, however, some issue still remains with their uses. This article summarize the limitations of currently existing premix insulin and discuss as to where we need to improvise with existing premix formulation, for better glucose control without frequent hypoglycaemia.

Featured Image

Why is it important?

This article compares and critically analyse the head to head studies of conventional premix (BHI 30) versus modern premix (BiAsp 30 or LisproMix 25) insulin and BiAsp 30 versus IDegAsp 30 (the latest premix co-formulation). The advantage and disadvantage with each premix insulin preparation is highlighted in this article.